Terranueva Corporation
TEQ.CN
Canadian Securities Exchange0.03
CAD
- -
- -
Terranueva Corporation
TEQ.CN
(Canadian Securities Exchange)
Recent
price
0.03
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Terranueva Corporation operates as a public company primarily engaged in the production and sale of high-quality medicinal and recreational cannabis. Founded with a commitment to leverage innovative technologies and research and development, the company focuses on operational efficiency to establish itself as a key player in the cannabis industry. Its core products encompass cannabis for both medical and recreational uses, produced under the Terranueva Pharma Corporation subsidiary, which is wholly owned and holds all necessary licenses from Health Canada. Terranueva Pharma operates in L'Assomption, Quebec, employing a modular production approach that integrates advanced process automation to ensure efficiency, quality, and stability of its cannabis output. The company serves both Canadian and international markets, capitalizing on opportunities created by the legalization of marijuana for recreational consumption. Recent major developments include the granting of an amendment to Terranueva Pharma Corporation’s cannabis production license by Health Canada, supporting the company’s expansion and innovation efforts in its manufacturing processes. The company has prioritized advancing technology in cannabis cultivation and processing, positioning itself to maintain competitive quality and cost control in its product offerings. Terranueva Corporation is publicly traded on the Canadian Securities Exchange under the ticker symbol TEQ, and it emphasizes governance, ethical principles, and sustainability in its strategic operations. Headquartered in Laval, Quebec, and with production facilities in L'Assomption, Terranueva continues to evolve in the pharmaceutical and cannabis sectors, focusing on research-driven growth and international market expansion. Its business operations pivot around delivering medicinal and recreational cannabis products that adhere to rigorous quality standards, driven by a mission to combine technology and efficiency from strain selection through to final product delivery. The company’s strategic orientation and regulatory approvals mark significant milestones in its pursuit of leadership in the emerging cannabis industry.